Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Neoplasm Staging"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 92451
Tytuł:
Facts and Myths About Stage Migration: Should the Will Rogers Phenomenon Ride off into the Distance?
Autorzy:
Fanti S; Department of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; University of Bologna, Bologna, Italy.
Lalumera E; Department of Life Quality Studies, University of Bologna, Rimini, Italy. Electronic address: .
Hicks R; Department of Medicine, St. Vincent's Medical School, University of Melbourne, Melbourne, Australia.
Pokaż więcej
Źródło:
European urology oncology [Eur Urol Oncol] 2023 Feb; Vol. 6 (1), pp. 1-3. Date of Electronic Publication: 2022 Jan 12.
Typ publikacji:
Editorial
MeSH Terms:
Neoplasm Staging*
Humans
Opinia redakcyjna
Szczegóły
Tytuł:
Adjuvant nodal field radiation in resected Stage III melanoma: A single-centre retrospective study in Christchurch, New Zealand.
Autorzy:
Leong TW; Canterbury Regional Cancer and Haematology Service, Christchurch Hospital, Christchurch, New Zealand.
McCook G; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
Frampton CM; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
Robinson BA; Canterbury Regional Cancer and Haematology Service, Christchurch Hospital, Christchurch, New Zealand.; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
James ML; Canterbury Regional Cancer and Haematology Service, Christchurch Hospital, Christchurch, New Zealand.; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
Pokaż więcej
Źródło:
Journal of medical imaging and radiation oncology [J Med Imaging Radiat Oncol] 2022 Oct; Vol. 66 (7), pp. 1003-1013. Date of Electronic Publication: 2022 Jun 01.
Typ publikacji:
Journal Article
MeSH Terms:
Melanoma*/diagnosis
Melanoma*/mortality
Melanoma*/radiotherapy
Melanoma*/surgery
Neoplasm Staging*
Skin Neoplasms*/diagnosis
Skin Neoplasms*/mortality
Skin Neoplasms*/radiotherapy
Skin Neoplasms*/surgery
Aged ; Female ; Humans ; Male ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; New Zealand/epidemiology ; Retrospective Studies ; Survival Rate ; Treatment Outcome
SCR Disease Name:
Melanoma, Cutaneous Malignant
Czasopismo naukowe
Szczegóły
Tytuł:
SUCCOR Risk: Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer.
Autorzy:
Manzour N; Department of Gynecology, Clinica Universidad de Navarra, Pamplona, Spain.
Chiva L; Department of Gynecology, Clinica Universidad de Navarra, Pamplona, Spain. .
Chacón E; Department of Gynecology, Clinica Universidad de Navarra, Pamplona, Spain.
Martin-Calvo N; Department of Preventive Medicine and Public Health, Universidad de Navarra, Pamplona, Spain.
Boria F; Department of Gynecology, Clínica Universidad de Navarra, Madrid, Spain.
Minguez JA; Department of Gynecology, Clinica Universidad de Navarra, Pamplona, Spain.
Alcazar JL; Department of Gynecology, Clinica Universidad de Navarra, Pamplona, Spain.
Pokaż więcej
Corporate Authors:
SUCCOR Study Group
Źródło:
Annals of surgical oncology [Ann Surg Oncol] 2022 Aug; Vol. 29 (8), pp. 4819-4829. Date of Electronic Publication: 2022 Apr 16.
Typ publikacji:
Journal Article; Validation Study
MeSH Terms:
Neoplasm Recurrence, Local*/diagnosis
Neoplasm Recurrence, Local*/pathology
Neoplasm Staging*
Uterine Cervical Neoplasms*/diagnosis
Uterine Cervical Neoplasms*/pathology
Uterine Cervical Neoplasms*/surgery
Female ; Humans ; Hysterectomy/methods ; Prognosis ; Recurrence ; Retrospective Studies ; Risk Assessment
Czasopismo naukowe
Szczegóły
Tytuł:
Evaluating long-term outcomes of three approaches to retroperitoneal staging in endometrial cancer.
Autorzy:
Bogani G; Department of Gynecological, Obstetrical and Urological Sciences, 'Sapienza' University of Rome, Italy. Electronic address: .
Di Donato V; Department of Gynecological, Obstetrical and Urological Sciences, 'Sapienza' University of Rome, Italy.
Papadia A; Department of Obstetrics and Gynecology, Ospedale Regionale di Lugano, Ente Ospedaliero Cantonale, University' of Italian Switzerland, Lugano, Switzerland.
Buda A; Division of Gynecologic Oncology, Michele e Pietro Ferrero Hospital, 12060 Verduno, Italy.
Casarin J; Department of Obstetrics and Gynecology, 'Filippo Del Ponte' Hospital, University of Insubria, Varese, Italy.
Multinu F; Division of Gynecologic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Plotti F; Department of Obstetrics and Gynecology, University Campus Biomedico of Rome, Rome, Italy.
Cuccu I; Department of Gynecological, Obstetrical and Urological Sciences, 'Sapienza' University of Rome, Italy.
D'Auge TG; Department of Gynecological, Obstetrical and Urological Sciences, 'Sapienza' University of Rome, Italy.
Gasparri ML; Department of Obstetrics and Gynecology, Ospedale Regionale di Lugano, Ente Ospedaliero Cantonale, University' of Italian Switzerland, Lugano, Switzerland.
Pinelli C; Department of Obstetrics and Gynecology, 'Filippo Del Ponte' Hospital, University of Insubria, Varese, Italy.
Perrone AM; Department of Obstetrics and Gynecology, Sant'Orsola Malpighi University, Hospital University of Bologna, 40138 Bologna, Italy.
Barra F; Academic Unit of Obstetrics and Gynaecology, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genova, Italy.
Sorbi F; Department of Biomedical, Experimental and Clinical Sciences, Division of Obstetrics and Gynecology, University of Florence, Florence, Italy.
Cromi A; Department of Obstetrics and Gynecology, 'Filippo Del Ponte' Hospital, University of Insubria, Varese, Italy.
Di Martino G; Gynecology Oncology Surgical Unit, Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
Palaia I; Department of Gynecological, Obstetrical and Urological Sciences, 'Sapienza' University of Rome, Italy.
Perniola G; Department of Gynecological, Obstetrical and Urological Sciences, 'Sapienza' University of Rome, Italy.
Ferrero S; Academic Unit of Obstetrics and Gynaecology, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genova, Italy.
De Iaco P; Department of Obstetrics and Gynecology, Sant'Orsola Malpighi University, Hospital University of Bologna, 40138 Bologna, Italy.
Perrone C; Department of Gynecological, Obstetrical and Urological Sciences, 'Sapienza' University of Rome, Italy.
Angioli R; Department of Obstetrics and Gynecology, University Campus Biomedico of Rome, Rome, Italy.
Luvero D; Department of Obstetrics and Gynecology, University Campus Biomedico of Rome, Rome, Italy.
Muzii L; Department of Gynecological, Obstetrical and Urological Sciences, 'Sapienza' University of Rome, Italy.
Ghezzi F; Department of Obstetrics and Gynecology, 'Filippo Del Ponte' Hospital, University of Insubria, Varese, Italy.
Landoni F; Gynecology Oncology Surgical Unit, Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
Mueller MD; Department of Obstetrics and Gynecology, University Hospital of Bern and University of Bern, Bern, Switzerland.
Benedetti Panici P; Department of Gynecological, Obstetrical and Urological Sciences, 'Sapienza' University of Rome, Italy.
Raspagliesi F; Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.
Pokaż więcej
Źródło:
Gynecologic oncology [Gynecol Oncol] 2022 Aug; Vol. 166 (2), pp. 277-283. Date of Electronic Publication: 2022 Jun 17.
Typ publikacji:
Journal Article
MeSH Terms:
Endometrial Neoplasms*/pathology
Neoplasm Staging*
Female ; Humans ; Lymph Node Excision/methods ; Lymph Nodes/pathology ; Lymph Nodes/surgery ; Retrospective Studies ; Sentinel Lymph Node Biopsy/methods
Czasopismo naukowe
Szczegóły
Tytuł:
Impact of the COVID-19 Outbreak on Cancer Staging in Brazil.
Autorzy:
de Sousa CFPM; Department of Radiation Oncology, Hospital Sírio Libanês, São Paulo, Brazil. Electronic address: .
de Castro Junior G; Department of Medical Oncology, Hospital Sírio Libanês, São Paulo, Brazil.
Starling MTM; Department of Radiation Oncology, Hospital Sírio Libanês, São Paulo, Brazil.
Restini FCF; Department of Radiation Oncology, Hospital Sírio Libanês, São Paulo, Brazil.
Rodrigues AN; Universidade Federal de Minas Gerais, Minas Gerais, Brazil.
de Castro Ribeiro HS; AC Camargo Cancer Center, São Paulo, Brazil.
Arruda GV; Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP, Ribeirão Preto, Brazil.
Hanna SA; Department of Radiation Oncology, Hospital Sírio Libanês, São Paulo, Brazil.
de Moraes FY; Department of Oncology, Queen's University, Kingston, Canada.
Marta GN; Department of Radiation Oncology, Hospital Sírio Libanês, São Paulo, Brazil.
Pokaż więcej
Źródło:
Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2023 Jun; Vol. 35 (6), pp. e404-e406. Date of Electronic Publication: 2023 Mar 22.
Typ publikacji:
Letter
MeSH Terms:
COVID-19*/epidemiology
Neoplasms*/epidemiology
Humans ; Neoplasm Staging ; Brazil/epidemiology ; SARS-CoV-2 ; Disease Outbreaks
Opinia redakcyjna
Szczegóły
Tytuł:
Stage I epithelial or stromal type Wilms tumors are low risk tumors: An analysis of patients treated on the SIOP-WT-2001 protocol in the UK-CCLG and GPOH studies (2001-2020).
Autorzy:
D'Hooghe E; Department of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Furtwängler R; Department of Paediatric Haematology and Oncology, Saarland University Hospital, Homburg, Germany.
Chowdhury T; Department of Haematology and Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Vokuhl C; Department of Pathology, Division of Paidopathology, University of Bonn, Bonn, Germany.
Al-Saadi R; UCL Great Ormond Street Institute of Child Health, London, UK.; Histopathology Department, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Pritchard-Jones K; UCL Great Ormond Street Institute of Child Health, London, UK.
Graf N; Department of Paediatric Haematology and Oncology, Saarland University Hospital, Homburg, Germany.
Vujanić GM; Department of Pathology, Sidra Medicine, Doha, Qatar.; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine-Qatar, Doha, Qatar.
Pokaż więcej
Źródło:
Cancer [Cancer] 2023 Jun 15; Vol. 129 (12), pp. 1930-1938. Date of Electronic Publication: 2023 Mar 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Kidney Neoplasms*/drug therapy
Kidney Neoplasms*/surgery
Kidney Neoplasms*/pathology
Wilms Tumor*/drug therapy
Wilms Tumor*/surgery
Child ; Humans ; Infant ; Retrospective Studies ; Neoplasm Staging ; Neoplasm Recurrence, Local/pathology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; United Kingdom/epidemiology
Czasopismo naukowe
Szczegóły
Tytuł:
Role of MRI in the Assessment of Cervical Cancer.
Autorzy:
Re GL; Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, Palermo, Italy.
Cucinella G; Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy; Unit of Gynecologic Oncology, ARNAS 'Civico-Di Cristina-Benfratelli', Palermo, Italy.
Zaccaria G; Unit of Gynecologic Oncology, ARNAS 'Civico-Di Cristina-Benfratelli', Palermo, Italy. Electronic address: .
Crapanzano A; Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, Palermo, Italy.
Salerno S; Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, Palermo, Italy.
Pinto A; Department of Radiology, CTO Hospital, Azienda Ospedaliera dei Colli, Naples, Italy.
Casto AL; Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, Palermo, Italy.
Chiantera V; Unit of Gynecologic Oncology, ARNAS 'Civico-Di Cristina-Benfratelli', Palermo, Italy.
Pokaż więcej
Źródło:
Seminars in ultrasound, CT, and MR [Semin Ultrasound CT MR] 2023 Jun; Vol. 44 (3), pp. 228-237. Date of Electronic Publication: 2023 Mar 28.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Uterine Cervical Neoplasms*/diagnostic imaging
Uterine Cervical Neoplasms*/pathology
Carcinoma, Squamous Cell*/diagnostic imaging
Carcinoma, Squamous Cell*/pathology
Female ; Humans ; Prognosis ; Neoplasm Staging ; Magnetic Resonance Imaging/methods
Czasopismo naukowe
Szczegóły
Tytuł:
Are patients with hepatocellular carcinoma and portal vein tumour thrombosis candidates for liver transplantation?
Autorzy:
Soin A; Medanta Institute of Liver Transplantation and Regenerative Medicine, Gurgaon, India.
Lesurtel M; Department of HPB Surgery & Liver Transplantation, APHP Beaujon Hospital, University of Paris Cité, 100, bd General Leclerc, 92110 Clichy, France.
Bhangui P; Medanta Institute of Liver Transplantation and Regenerative Medicine, Gurgaon, India.
Cocchi L; Department of HPB Surgery & Liver Transplantation, APHP Beaujon Hospital, University of Paris Cité, 100, bd General Leclerc, 92110 Clichy, France.
Bouattour M; Department of Hepatology, APHP Beaujon Hospital, University of Paris Cité, 100, Bd General Leclerc, 92110 Clichy, France.
Clavien PA; Department of Surgery and Transplantation, University of Zurich, Switzerland. Electronic address: .
Pokaż więcej
Źródło:
Journal of hepatology [J Hepatol] 2023 Jun; Vol. 78 (6), pp. 1124-1129.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Hepatocellular*/complications
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/complications
Liver Neoplasms*/surgery
Liver Transplantation*/methods
Venous Thrombosis*/etiology
Venous Thrombosis*/surgery
Humans ; Portal Vein/pathology ; Neoplasm Staging ; Treatment Outcome ; Retrospective Studies
Czasopismo naukowe
Szczegóły
Tytuł:
Nasopharyngeal carcinoma. A "different" head and neck tumour. Part B: treatment, prognostic factors, and outcomes.
Autorzy:
Cantù G; Former Director of Otorhinolaryngology and Cranio-Maxillo-Facial Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Pokaż więcej
Źródło:
Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale [Acta Otorhinolaryngol Ital] 2023 Jun; Vol. 43 (3), pp. 155-169.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Nasopharyngeal Neoplasms*/diagnosis
Nasopharyngeal Neoplasms*/therapy
Nasopharyngeal Neoplasms*/pathology
Head and Neck Neoplasms*/diagnosis
Head and Neck Neoplasms*/therapy
Head and Neck Neoplasms*/pathology
Radiotherapy, Intensity-Modulated*
Humans ; Nasopharyngeal Carcinoma/therapy ; Nasopharyngeal Carcinoma/pathology ; Prognosis ; Combined Modality Therapy ; Neoplasm Staging ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Tytuł:
Predictors and outcomes of positive surgical margins after local excision of clinical T1 rectal cancer: A National Cancer Database analysis.
Autorzy:
Freund MR; Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, Weston, FL; Department of General Surgery, Shaare Zedek Medical Center, the Hebrew University Faculty of Medicine, Jerusalem, Israel. Electronic address: https://twitter.com/mikifreund.
Horesh N; Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, Weston, FL; Department of Surgery and Transplantations, Sheba Medical Center, Ramat Gan, Israel. Electronic address: https://twitter.com/Nirhoresh1.
Emile SH; Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, Weston, FL; Colorectal Surgery Unit, Mansoura University, Faculty of Medicine, Egypt. Electronic address: https://twitter.com/dr_samehhany81.
Garoufalia Z; Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, Weston, FL. Electronic address: https://twitter.com/ZGaroufalia.
Gefen R; Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, Weston, FL; Department of General Surgery, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel. Electronic address: https://twitter.com/RachellGefen.
Wexner SD; Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, Weston, FL. Electronic address: .
Pokaż więcej
Źródło:
Surgery [Surgery] 2023 Jun; Vol. 173 (6), pp. 1359-1366. Date of Electronic Publication: 2023 Mar 21.
Typ publikacji:
Journal Article
MeSH Terms:
Rectal Neoplasms*/pathology
Adenocarcinoma*
Carcinoma*/pathology
Humans ; Male ; Margins of Excision ; Retrospective Studies ; Treatment Outcome ; Neoplasm Staging ; Neoplasm Recurrence, Local/pathology
Czasopismo naukowe
Szczegóły
Tytuł:
Prognostic Value of Body Mass Index in Stage II/III Colon Cancer: Posthoc Analysis From the TOSCA Trial.
Autorzy:
Basile D; Department of Medical Oncology, San Bortolo General Hospital, Vicenza, Italy.
Rosati G; Medical Oncology Unit, San Carlo Hospital, Potenza, Italy.
Bergamo F; Medical Oncology Unit 1, Istituto Oncologico Veneto-IOV IRCCS, Padova, Italy.
Garattini SK; Medical Oncology Unit, Azienda Ospedaliero Universitaria Santa Maria della Misericordia, Udine, Italy.
Banzi M; Medical Oncology Unit, AUSL-IRCCS, Reggio Emilia, Italy.
Zampino M; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, Istituto Europeo di Oncologia-IRCCS, Milano, Italy.
Bozzarelli S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (MI), Italy.
Marchetti P; Medical Oncology Unit Sant'Andrea Hospital, Sapienza University of Rome and IRCCS Istituto Dermopatico dell'Immacolata, Rome, Italy.
Galli F; Methodology for Clinical Research Laboratory, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Galli F; Methodology for Clinical Research Laboratory, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Longarini R; Medical Oncology Unit San Gerardo Hospital, Monza, Italy.
Zaniboni A; Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy.
Ferrari D; Medical Oncology Unit, Azienda Ospedaliera San Paolo, Milano, Italy.
De Placido S; Medical Oncology Unit Università Federico II, Napoli, Italy.
Frassineti LG; Medical Oncology Unit IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (FO), Italy.
Nicolini M; Medical Oncology Unit Azienda USL Romagna, Cattolica, Rimini, Italy.
Cinieri S; Medical Oncology Unit Ospedale Antonio Perrino, Brindisi, Italy.
Priscindiaro M; Medical Oncology Unit1, Fondazione Istituto Nazionale Tumori-IRCCS, Milano, Italy.
Ziranu P; Medical Oncology, University Hospital and University of Cagliari, Cagliari, Italy.
Caccialanza R; Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Pastorino A; Medical Oncology Unit, IRCCS San Martino-IST-Genova, Genova, Italy.
Mosconi S; Cancer Center ASST Papa Giovanni XXIII, Bergamo, Italy.
Aprile G; Department of Medical Oncology, San Bortolo General Hospital, Vicenza, Italy. Electronic address: .
Pokaż więcej
Źródło:
Clinical colorectal cancer [Clin Colorectal Cancer] 2023 Jun; Vol. 22 (2), pp. 190-198. Date of Electronic Publication: 2023 Feb 05.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Colonic Neoplasms*
Humans ; Body Mass Index ; Chemotherapy, Adjuvant/adverse effects ; Neoplasm Staging ; Obesity/complications ; Prognosis
Czasopismo naukowe
Szczegóły
Tytuł:
Surgical resection as a predictor of cancer-specific survival by stage at diagnosis and cancer type, United States, 2006-2015.
Autorzy:
Raoof S; Memorial Sloan Kettering Cancer Center, USA. Electronic address: .
Clarke CA; GRAIL, LLC, 1525 O'Brien Dr, Menlo Park, CA 94025, USA.
Hubbell E; GRAIL, LLC, 1525 O'Brien Dr, Menlo Park, CA 94025, USA.
Chang ET; GRAIL, LLC, 1525 O'Brien Dr, Menlo Park, CA 94025, USA.
Cusack J; Massachusetts General Hospital, USA.
Pokaż więcej
Źródło:
Cancer epidemiology [Cancer Epidemiol] 2023 Jun; Vol. 84, pp. 102357. Date of Electronic Publication: 2023 Apr 05.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*
Lung Neoplasms*
Humans ; United States/epidemiology ; Neoplasm Staging ; Survival Rate
Czasopismo naukowe
Szczegóły
Tytuł:
Prevalence of long-term opioid use after radiotherapy for cervical cancer in a Brazilian cancer center.
Autorzy:
de Albuquerque LZ; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), 37 André Cavalcanti Street, 5th floor, Annex Building, Downtown, Rio de Janeiro, RJ, ZIP Code 20231-050, Brazil. lucas_.
da Silva JL; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), 37 André Cavalcanti Street, 5th floor, Annex Building, Downtown, Rio de Janeiro, RJ, ZIP Code 20231-050, Brazil.
Dos Santos ALS; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), 37 André Cavalcanti Street, 5th floor, Annex Building, Downtown, Rio de Janeiro, RJ, ZIP Code 20231-050, Brazil.
Rodrigues IP; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), 37 André Cavalcanti Street, 5th floor, Annex Building, Downtown, Rio de Janeiro, RJ, ZIP Code 20231-050, Brazil.
de Melo AC; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), 37 André Cavalcanti Street, 5th floor, Annex Building, Downtown, Rio de Janeiro, RJ, ZIP Code 20231-050, Brazil.
Pokaż więcej
Źródło:
Journal of cancer survivorship : research and practice [J Cancer Surviv] 2023 Jun; Vol. 17 (3), pp. 686-693. Date of Electronic Publication: 2022 Feb 11.
Typ publikacji:
Journal Article
MeSH Terms:
Uterine Cervical Neoplasms*/epidemiology
Uterine Cervical Neoplasms*/radiotherapy
Uterine Cervical Neoplasms*/pathology
Cancer Survivors*
Brachytherapy*/adverse effects
Humans ; Female ; Middle Aged ; Analgesics, Opioid/therapeutic use ; Prevalence ; Brazil/epidemiology ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Retrospective Studies
Czasopismo naukowe
Szczegóły
Tytuł:
Clinicopathological characteristics, survival outcome and prognostic factors of very young gastric cancer.
Autorzy:
Zhong N; Department of Oncology, The First Affiliated Hospital, Nanchang University, Nanchang, 330006, Jiangxi, China.
Yu Y; Department of Oncology, The First Affiliated Hospital, Nanchang University, Nanchang, 330006, Jiangxi, China.
Chen J; Department of Oncology, The First Affiliated Hospital, Nanchang University, Nanchang, 330006, Jiangxi, China.
Shao Y; Department of General Practice, The Second Affiliated Hospital, Nanchang University, Nanchang, 330008, Jiangxi, China.
Peng Z; Department of Oncology, Jiangxi Tumor Hospital, Nanchang University, Nanchang, 330029, Jiangxi, China.
Li J; Department of Oncology, The First Affiliated Hospital, Nanchang University, Nanchang, 330006, Jiangxi, China. .
Pokaż więcej
Źródło:
Clinical and experimental medicine [Clin Exp Med] 2023 Jun; Vol. 23 (2), pp. 437-445. Date of Electronic Publication: 2022 Apr 22.
Typ publikacji:
Journal Article
MeSH Terms:
Stomach Neoplasms*/pathology
Humans ; Female ; Young Adult ; Adult ; Male ; Prognosis ; Neoplasm Staging ; Retrospective Studies ; Gastrectomy
Czasopismo naukowe
Szczegóły
Tytuł:
Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas.
Autorzy:
Goldschmid H; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Kluck K; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Ball M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany.
Kirchner M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Allgäuer M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Winter H; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany; Department of Thoracic Surgery, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany.
Herth F; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany; Department of Pulmonology, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany.
Heußel CP; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany; Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany.
Pullamsetti SS; Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
Savai R; Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany; Institute for Lung Health (ILH), Justus Liebig University, Giessen, Germany.
Yong TTK; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; Department of Anatomical Pathology, Department of Molecular Pathology at Singapore General Hospital, Singapore.
Schirmacher P; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Center for Personalized Medicine Heidelberg (ZPM), Heidelberg, Germany.
Peters S; Oncology Department, Lausanne University Hospital, Lausanne, Switzerland.
Thomas M; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany; Department of Thoracic Oncology, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany.
Christopoulos P; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany; Department of Thoracic Oncology, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany.
Budczies J; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: .
Kazdal D; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Germany. Electronic address: .
Pokaż więcej
Źródło:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Jun; Vol. 180, pp. 107212. Date of Electronic Publication: 2023 Apr 23.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/immunology
Adenocarcinoma of Lung*/therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/immunology
Lung Neoplasms*/therapy
Immune Evasion*/genetics
AMP-Activated Protein Kinase Kinases*/genetics
Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology ; Humans ; Mutation ; Neoplasm Staging
Czasopismo naukowe
Szczegóły
Tytuł:
A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [ F]FDG-PET/CT parameters.
Autorzy:
Rogasch JMM; Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. .; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany. .
Michaels L; Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.; Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Baumgärtner GL; Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Frost N; Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Rückert JC; Department of General, Visceral, Vascular and Thoracic Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Neudecker J; Department of General, Visceral, Vascular and Thoracic Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Ochsenreither S; Department of Hematology and Medical Oncology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Charité Comprehensive Cancer Center, Berlin, Germany.
Gerhold M; Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Schmidt B; Department of Internal Medicine - Pneumology and Sleep Medicine, DRK Kliniken Berlin Mitte, Berlin, Germany.
Schneider P; Department of Thoracic Surgery, DRK Kliniken Berlin Mitte, Berlin, Germany.
Amthauer H; Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Furth C; Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Penzkofer T; Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jun; Vol. 50 (7), pp. 2140-2151. Date of Electronic Publication: 2023 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/pathology
Humans ; Mediastinum/diagnostic imaging ; Positron Emission Tomography Computed Tomography/methods ; Fluorodeoxyglucose F18 ; Lymphatic Metastasis/diagnostic imaging ; Lymphatic Metastasis/pathology ; Retrospective Studies ; Lymph Nodes/pathology ; Neoplasm Staging
Czasopismo naukowe
Szczegóły
Tytuł:
Vaginal dilator use more than 9 months is a main prognostic factor for reducing G2‑late vaginal complications in 3D‑vaginal‑cuff brachytherapy (interventional radiotherapy)?
Autorzy:
Zhang Y; Cancer Center, Henan Provincial People's Hospital, Zhengzhou, China.
Noorian F; Radiation Oncology Department, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.; Fonaments Clínics Department Faculty of Medicine, Universitat de Barcelona, C/ Casanova 153, 08036, Barcelona, Spain.
Abellana R; Fonaments Clínics Department Faculty of Medicine, Universitat de Barcelona, C/ Casanova 153, 08036, Barcelona, Spain.
Rochera J; Radiation Oncology Department, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Herreros A; Radiation Oncology Department, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.; Fonaments Clínics Department Faculty of Medicine, Universitat de Barcelona, C/ Casanova 153, 08036, Barcelona, Spain.
Antelo G; Radiation Oncology Department, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Lancellotta V; Dipartimento di Diagnostica per Immagini, U.O.C. Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Radioterapia Oncologica ed Ematologia, 00168, Rome, Italy.
Tagliaferri L; Dipartimento di Diagnostica per Immagini, U.O.C. Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Radioterapia Oncologica ed Ematologia, 00168, Rome, Italy.
Han Q; Cancer Center, Henan Provincial People's Hospital, Zhengzhou, China.
Torne A; Gynecological Cancer Unit, Hospital Clinic-Universitat de Barcelona, Barcelona, Spain.
Rovirosa A; Radiation Oncology Department, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. .; Fonaments Clínics Department Faculty of Medicine, Universitat de Barcelona, C/ Casanova 153, 08036, Barcelona, Spain. .; Gynecological Cancer Unit, Hospital Clinic-Universitat de Barcelona, Barcelona, Spain. .
Pokaż więcej
Źródło:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2023 Jun; Vol. 25 (6), pp. 1748-1755. Date of Electronic Publication: 2023 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Brachytherapy*/adverse effects
Brachytherapy*/methods
Endometrial Neoplasms*/radiotherapy
Endometrial Neoplasms*/surgery
Endometrial Neoplasms*/pathology
Female ; Humans ; Retrospective Studies ; Prognosis ; Vagina/pathology ; Neoplasm Staging
Czasopismo naukowe
Szczegóły
Tytuł:
Preoperative downstaging of pancreatic cancer is associated with improved survival after multi-agent chemotherapy, but not after radiation.
Autorzy:
Nicolais L; Division of Surgical Oncology, Tufts University School of Medicine-Maine Medical Center, Portland, ME, USA; Tufts University Clinical and Translational Science Graduate Program, Graduate School of Biomedical Sciences, Boston, MA, USA.
Brown AW; Division of Surgical Oncology, Tufts University School of Medicine-Maine Medical Center, Portland, ME, USA.
Mohamed A; Division of Surgical Oncology, Tufts University School of Medicine-Maine Medical Center, Portland, ME, USA.
Clark DE; Division of Surgical Oncology, Tufts University School of Medicine-Maine Medical Center, Portland, ME, USA.
Fitzgerald TL; Division of Surgical Oncology, Tufts University School of Medicine-Maine Medical Center, Portland, ME, USA. Electronic address: .
Pokaż więcej
Źródło:
Surgical oncology [Surg Oncol] 2023 Jun; Vol. 48, pp. 101939. Date of Electronic Publication: 2023 Mar 31.
Typ publikacji:
Journal Article
MeSH Terms:
Pancreatic Neoplasms*/pathology
Humans ; Retrospective Studies ; Neoadjuvant Therapy ; Chemotherapy, Adjuvant ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Neoplasm Staging ; Treatment Outcome
SCR Disease Name:
Pancreatic Carcinoma
Czasopismo naukowe
Szczegóły
Tytuł:
Pathological response and prognostic factors of neoadjuvant PD-1 blockade combined with chemotherapy in resectable oesophageal squamous cell carcinoma.
Autorzy:
Wang H; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Jiang Z; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Wang Q; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Wu T; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Guo F; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Xu Z; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Yang W; Department of Thoracic Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Yang S; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Feng S; Department of Radiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Wang X; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Chen S; Division of Interventional Ultrasound, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Cheng C; Department of Thoracic Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. Electronic address: .
Chen W; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. Electronic address: .
Pokaż więcej
Źródło:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Jun; Vol. 186, pp. 196-210. Date of Electronic Publication: 2023 Mar 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/therapy
Esophageal Neoplasms*/pathology
Humans ; Prognosis ; Programmed Cell Death 1 Receptor/therapeutic use ; Neoadjuvant Therapy ; Neoplasm Staging ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Paclitaxel ; Carboplatin/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
Determining the optimal radiation-surgery interval (RSI) for oncologic proctectomy following radiotherapy for rectal adenocarcinoma.
Autorzy:
Bobel MC; Department of Surgery, Trinity Health Ann Arbor, Ypsilanti, Michigan, USA.
McGee MF; Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA.
Pokaż więcej
Źródło:
Journal of surgical oncology [J Surg Oncol] 2023 Jun; Vol. 127 (8), pp. 1252-1258.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Adenocarcinoma*/radiotherapy
Adenocarcinoma*/surgery
Adenocarcinoma*/pathology
Rectal Neoplasms*/radiotherapy
Rectal Neoplasms*/surgery
Rectal Neoplasms*/pathology
Proctectomy*
Humans ; Treatment Outcome ; Neoplasm Staging ; Retrospective Studies ; Neoadjuvant Therapy/adverse effects
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 92451

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies